Legend Biotech (LEGN) Valuation Check After Recent Share Price Pullback [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
Legend Biotech (LEGN) has drawn investor attention after a sharp share price pullback, with the stock down about 20% over the past month and roughly 46% over the past 3 months. See our latest analysis for Legend Biotech. The recent slide extends a weak run, with a 7 day share price return of 9.55%, a 30 day share price return of 20.27% and a 12 month total shareholder return of 54.03%. This suggests momentum has been fading as investors reassess growth potential and risks. If Legend Biotech's volatility has you reassessing your watchlist, this could be a good moment to see what else is moving across healthcare stocks With Legend Biotech now trading at US$17.15, alongside an intrinsic discount estimate of 86% and a recent loss of US$239.701 million, you have to ask: is this a buying opportunity or is future growth already priced in? Legend Biotech's most followed narrative tags a fair value of about $72.41 against the last close of $17.15, framing a wide valuation gap that r
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss [Yahoo! Finance]Yahoo! Finance
- GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San FranciscoPR Newswire
- Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline [Yahoo! Finance]Yahoo! Finance
- Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds [Seeking Alpha]Seeking Alpha
- Legend Biotech (NASDAQ:LEGN) had its price target lowered by analysts at HC Wainwright from $60.00 to $50.00. They now have a "buy" rating on the stock.MarketBeat
LEGN
Sec Filings
- 1/23/26 - Form 6-K
- 1/21/26 - Form 6-K
- 1/14/26 - Form 6-K
- LEGN's page on the SEC website